N/A N=172 The Pathway PVD Study for Percutaneous Peripheral Vascular Interventions
Peripheral Artery Disease
Primary: Major Adverse Events (MAEs) Within 30 Days — 2 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=51 Oral Pathology Asynchronous Telementoring Pilot Study
Oral Cancer
Primary: Percentage of Dental Patients Who Strongly Agreed or Agreed That the Use of an Intra-Oral Camera By Their Dentists Helped Them to Better Understand Oral Cancer Screening…
N/A N=2,000 Pivotal Study for Validation of Philips Dx (PDx)
Pathologic Processes
Primary: Major Discordance Rate — 4.4; 4.7 percentage of major discordance
Phase 2 N=673 My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Neoplasms · Solid Tumors · Biliary Cancer
Primary: Percentage of Participants in All Tumor-Pathway Cohorts With Overall Response, as Assessed by the Investigator — 21.0; 19.5; 25.5; 33.3 Percentage of Participants
Phase 2 N=6 A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib
HER2 Amplified Breast Cancer
Primary: Changes in Colon Pathology — 2; 2 participants
N/A N=2,000 Primary Diagnosis Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System
Pathology
Primary: Major Discordance Rate — 3.5; 3.1 Percentage of Major Discordances
Phase 2 N=10 Histopathology Following CCH Injection
Characteristics of Subcutaneous Tissue
Primary: Number of Participants With a Histologic Change in a Tissue Specimen That Was Injected With CCH — 2; 1; 1; 2 Participants
Phase 1 N=3 18F-AV-1451 High Resolution Autopsy Study
Alzheimer's Disease
Primary: Relationship of Flortaucipir Scan and Pathology - Whole Cortical Composite Region — 0.429 Correlation coefficient — p=<0.001
N/A N=355 Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
Gastro-Intestinal Disorder
Primary: Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis — 283 participants
N/A N=102 Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease
Infrainguinal Peripheral Artery Disease · Peripheral Arterial Disease · PAD
Primary: Primary Efficacy: Acute Procedural Success — 69 Lesions
N/A N=30 Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples
Breast Cancer
Primary: Percentage of Participants With Immunohistochemical (IHC) Evaluation Between Site A and Others (Sites B, C, D and E) — 16.7; 12.5; 0.0; 8.3 percentage of participants
N/A N=25 Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Lung Cancer
Primary: Number of Red Fluorescent [i.e., Cancer] Cells (RFCs) in Sputum From Healthy Participants — 0 number of RFCs per participant
Phase 3 N=226 Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
Alzheimer's Disease
Primary: Correlation of Florbetapir-PET Image and Amyloid Plaque Density — 0.78 Correlation coefficient — p=<0.0001